# Current state
No new comprehensive US-China tariff/trade agreement has been announced since the Oct 30, 2025 Busan truce (effective Nov 10, 2025); that truce is fraying, not being formalized. As of the most recent reporting (Aug 2026), the US imposed a new Section 301 tariff (effective July 24, 2026) and China retaliated with countermeasures (Aug 5, 2026); Treasury Sec. Bessent says the US is "not in a rush" to extend the truce. Polymarket's equivalent market prices YES at 91.9%, up from ~70% a month ago, implying the market expects some qualifying "mutual agreement" event (extension/formalization) before Dec 31, 2026 — likely tied to Xi's planned Sept 24, 2026 US visit.
# Timeline of key events
- 2020-01: Phase One agreement signed (confirmed, historical baseline).
- 2025-05: Geneva tariff-truce agreement reached (confirmed).
- 2025-08: Truce extension (confirmed).
- 2025-10-30: Trump-Xi Busan summit produces "Busan framework" — one-year truce (confirmed; White House fact sheet, CNBC).
- 2025-11-10: US cuts fentanyl-related tariffs by 10pp, suspends heightened reciprocal tariffs until 2026-11-10; China suspends retaliatory tariffs/non-tariff countermeasures until 2026-12-31; China pauses rare-earth export controls for one year (confirmed).
- 2026-05-13/15: Trump state visit to Beijing — largely symbolic, no detailed tariff agreement announced; Trump says tariffs weren't discussed (reported, CNN/Wikipedia).
- 2026-05-~: Trump invites Xi for a reciprocal US state visit on 2026-09-24 (reported).
- 2026-05-20: US and China reportedly agree on terms to restore previously-voided US tariffs but have NOT agreed on extending the one-year truce (reported).
- 2026-07-22: Rubio and Wang Yi discuss Chinese president's planned US visit (reported).
- 2026-07-23/24: USTR imposes new 12.5% Section 301 tariff on China (forced-labor enforcement), raising overall tariff rate ~2.5pp (confirmed).
- 2026-07-30/31: China expresses "serious concern" over new US trade restrictions (reported).
- 2026-08-05: China announces countermeasures against US trade sanctions (confirmed, multiple outlets).
- 2026-08-08: Reports Trump seeking expanded unilateral tariff authority (up to 100%) via pending legislation (reported).
- Ongoing (as of Aug 2026): Bessent states US is "not in a rush" to extend Busan truce, calls situation "stable" (reported).
# Event
Will the US and China officially/mutually announce a tariff agreement between market creation and Dec 31, 2026?
# Outcomes to forecast
- Yes
- No
# Kalshi market anchor
No Kalshi-direct YES price was returned for this specific ticker in the research pull (tool output absent) — this is a gap. The only Kalshi pricing available is for RELATED-but-distinct markets: "Will the U.S. enact a free trade agreement with China? (Before 2029)" at 15% (down 14pts in 30 days), which is a much stricter/longer-horizon bar than this question's "mutual agreement" definition. Treat the Polymarket price (91.9% YES, +3.3% 7d, +2.75% 30d, range 69.5–92.2% over 83 days) as the best available cross-market anchor for this specific contract.
# Sub-question answers
1. **Polymarket price/history & creation vs. Busan truce** — Current Polymarket YES = 91.9%; 83 days of data with a low of 69.5%, suggesting market creation was likely around/after the Oct 30, 2025 Busan truce (or shortly before), meaning the truce itself may already be "priced in" as satisfying resolution, or the market anticipates a further formal deal. [polymarket_direct]
2. **Nov 2025 truce status/expiry** — Fentanyl tariff cut (10pp) and reciprocal-tariff suspension run to Nov 10, 2026; China's retaliatory-tariff suspension runs to Dec 31, 2026; rare-earth export control pause is one year (~Oct/Nov 2026). Multiple expiry dates cluster near the question's Dec 31, 2026 close. [claude_news, White House fact sheet]
3. **2026 negotiations/summits** — Trump made a state visit to Beijing May 13-15, 2026 (little tariff substance); Xi invited for a US state visit Sept 24, 2026, a plausible venue for a further announcement before year-end. [claude_news, Wikipedia]
4. **Base rate** — Historical spacing between mutual announcements (Phase One 2020 → Geneva 2025 → Aug 2025 extension → Busan Oct 2025) shows a regime shift from ~64-month gaps to ~2.6-3-month gaps in 2025; blended 2026 base rate estimated 65-85%, well above the long-run Poisson estimate of 40-50%. [code_execution]
5. **Escalation risks** — New Section 301 tariff (July 2026, 12.5%) and Chinese countermeasures (Aug 2026) show active friction; Taiwan and rare-earths remain flashpoints; Bessent explicitly signals no urgency to extend the truce. [claude_news, gdelt_news]
6. **Other market pricing** — Kalshi's "free trade agreement" market (15%, falling) prices a stricter outcome much lower, consistent with this question's broader "any mutual agreement" definition being easier to satisfy. No direct Polymarket/Kalshi arbitrage match found otherwise. [kalshi_related, polymarket_related]
# Key facts (high-confidence, factual)
1. [White House/CNBC] Busan truce (Oct 30, 2025) is confirmed and includes reciprocal tariff/export-control concessions.
2. [claude_news] No comprehensive new deal has replaced Busan framework as of mid-2026; relationship termed a "tactical truce."
3. [claude_news] July 2026 US Section 301 tariff and Aug 2026 Chinese countermeasures represent fresh escalation, not resolution.
4. [Wikipedia] Long-run US-China trade war context confirms cyclical escalation/de-escalation pattern since 2018.
# Cross-market signals
- Kalshi related: "Free trade agreement by 2029" at 15% (stricter bar, declining) — not directly comparable.
- Polymarket: 91.9% YES on this exact question, rising trend.
- Sportsbook implied: none available.
# Analyst opinions and speculation
- Geopolitical Monitor: truce is fragile, hard to see it holding through 2026 given Taiwan/rare-earth tensions.
- Bloomberg (Dec 2025): "fragile trade truce" heading into 2026.
- code_execution model: recent cadence suggests 65-85% probability of a qualifying announcement in any 12-month window in the current environment.
# Directional lean per outcome
- **Yes**: Truce renewal/extension deadlines (Nov 10 and Dec 31, 2026) create natural forcing events; Xi's Sept 24, 2026 US visit is a plausible deal venue; Polymarket already at 91.9% and rising; broad resolution criteria (even informal-but-confirmed mutual tariff cuts count).
- **No**: Bessent's "no rush to extend" comment, fresh Section 301 tariffs and Chinese countermeasures (mid-2026) show active de-escalation stalling; no formal deal materialized from the May 2026 Trump-Xi summit despite high expectations.
# Gaps / unknowns
- No confirmed Kalshi-direct YES price for this specific ticker was retrieved — must be sourced before finalizing.
- Unclear whether the original Oct 2025 Busan truce itself already satisfies this market's resolution criteria (would explain high Polymarket price) or whether a distinct new announcement is required.
- Outcome of Sept 24, 2026 Xi-US visit (post-dates available research) is unknown and highly decision-relevant.
# Calibration anchors
- Polymarket YES price (anchor): 91.9%, uptrend over 7/30 days.
- Kalshi comparable market (stricter FTA definition): 15%, declining — illustrates definitional sensitivity.
- Recent precedent: 3 mutual tariff announcements in 2025 alone (Geneva, Aug extension, Busan) support a high base rate for further action in 2026.